Oral sucrosomial iron versus intravenous iron in anemic cancer patients without iron deficiency receiving darbepoetin alfa: a pilot study
ConclusionIn cancer patients with chemotherapy-related anemia receiving darbepoetin alfa, sucrosomial oral iron provides similar increase in Hb levels and Hb response, with higher tolerability without the risks or side effects of IV iron.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research
More News: Anemia | Aranesp | Cancer | Cancer & Oncology | Chemotherapy | Iron | Oral Cancer | Statistics | Study